Condition

Type 2 Diabetes Mellitus

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 1,865 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1,865
Recruiting38
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal ImpairmentNCT07807059 · 2026-09-09
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesNCT07743450 · 2026-08-28
RECRUITING
Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 DiabetesNCT07835360 · 2026-07-10
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinNCT07664553 · 2026-07-08
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusNCT07662213 · 2026-07-06
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinNCT07662135 · 2026-07-06
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusNCT07662044 · 2026-07-06
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusNCT07662109 · 2026-07-06
RECRUITING
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk ScoreNCT07554469 · 2026-05-26
RECRUITING
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes MellitusNCT07527650 · 2026-05-18
RECRUITING
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemNCT07579702 · 2026-05-13
RECRUITING
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 DiabetesNCT07521475 · 2026-04-30
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23
RECRUITING
POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.NCT07433192 · 2026-03-02
RECRUITING
Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes MellitusNCT07373938 · 2026-01-25
RECRUITING
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South KoreaNCT07232537 · 2025-11-20
RECRUITING
The GRoceries Aimed at Increasing Nutrition StudyNCT07167004 · 2025-10-14
RECRUITING
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes MellitusNCT06704672 · 2025-04-14
RECRUITING
Antidiabetic Effect of Olive Pomace OilNCT06723886 · 2025-01-15
RECRUITING
Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes MellitusNCT04670666 · 2024-11-18
RECRUITING
Current Status of Islet Alpha Cell Function in Patients with Type 2 DiabetesNCT06825182 · 2024-11-07
RECRUITING
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek ProgrammeNCT07658755 · 2024-10-01
RECRUITING
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive ImpairmentNCT07711171 · 2024-08-19
RECRUITING
Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional StudyNCT07447362 · 2024-07-24
RECRUITING
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsNCT06278207 · 2024-05-15
RECRUITING
Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 DiabetesNCT06826235 · 2024-05-14
RECRUITING
Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and ControlsNCT06277466 · 2024-01-01
RECRUITING
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)NCT06169033 · 2024-01-01
RECRUITING
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DMNCT06256419 · 2024-01-01
RECRUITING
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney DiseaseNCT06838416 · 2023-11-17
RECRUITING
A Study of Glycemic Control in Left Ventricular AssistNCT05933161 · 2023-11-10
RECRUITING
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan AfricaNCT05881447 · 2023-06-21
RECRUITING
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)NCT07083336 · 2022-06-05
RECRUITING
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 DiabetesNCT05553093 · 2022-03-15
RECRUITING
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)NCT05008276 · 2021-09-27
RECRUITING
Nanshan Elderly Cohort StudyNCT03569735 · 2018-05-26
RECRUITING
China Diabetes Registry by Metabolic Management CenterNCT03811470 · 2017-05-31
RECRUITING
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes MellitusNCT05697991 · 2015-03-23
RECRUITING
Testing a Diabetes Care Program in Rural and Low-Income ClinicsNCT07538505 · 2027-03-01
NOT_YET_RECRUITING
Diabetes Distress, Medication Adherence Barriers, Self-Management, and Glycemic Control in Adults With Type 2 DiabetesNCT07861308 · 2026-12-15
NOT_YET_RECRUITING
Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 DiabetesNCT07854990 · 2026-10-20
NOT_YET_RECRUITING
Soluble TREM-1 in Diabetes-Associated Cardiovascular ComplicationsNCT07847112 · 2026-10-01
NOT_YET_RECRUITING
Platelet Indices and Blood Groups in Type 2 Diabetes Vascular ComplicationsNCT07847099 · 2026-09-26
NOT_YET_RECRUITING
Continued Access to the Endogenex System for Participants in the ReCET Pivotal StudyNCT07197788 · 2026-09-01
ENROLLING_BY_INVITATION
Incretin Therapy and Exercise in Type 2 DiabetesNCT07833813 · 2026-09-01
NOT_YET_RECRUITING
Integrated Diabetes and Oral Health Care in OmanNCT07809477 · 2026-09-01
NOT_YET_RECRUITING
Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)NCT07723820 · 2026-09-01
NOT_YET_RECRUITING
Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney DiseaseNCT07773467 · 2026-09-01
NOT_YET_RECRUITING
Efficacy and Safety of Hebenrun in Patients With Type 2 DiabetesNCT07768280 · 2026-09-01
NOT_YET_RECRUITING
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 DiabetesNCT07755150 · 2026-08-30
NOT_YET_RECRUITING
"Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"NCT07099482 · 2026-08-30
NOT_YET_RECRUITING
Huangqi Gegen Decoction for Endothelial Function in Type 2 Diabetes at Very High ASCVD RiskNCT07775664 · 2026-08-04
ACTIVE_NOT_RECRUITING
The Therapeutic Effects of Ceylon Cinnamon Supplementation and a Self-Efficacy Educational Program on Glycemic Control, Lipid Profiles, and Pain in Type 2 Diabetes Mellitus With Painful Diabetic Peripheral NeuropathyNCT07757399 · 2026-08-01
NOT_YET_RECRUITING
Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized TrialNCT07707518 · 2026-07-30
NOT_YET_RECRUITING
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor AnalysisNCT07717697 · 2026-07-30
NOT_YET_RECRUITING
Vitamin D Status and Lipid Profile in Obese Adults With Type 2 DiabetesNCT07729553 · 2026-07-25
NOT_YET_RECRUITING
Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular DiseaseNCT07704190 · 2026-07-15
NOT_YET_RECRUITING
LLM-Assisted Diabetes and Hypertension Management by Village DoctorsNCT07678658 · 2026-07-01
NOT_YET_RECRUITING
ULTRASONOGRAPHIC EVALUATION OF TALAR CARTILAGE THICKNESS IN PATIENTS WITH DIABETIC POLYNEUROPATHYNCT07801131 · 2026-06-19
COMPLETED
Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 DiabetesNCT07569744 · 2026-05-01
COMPLETED

Trial status mix

COMPLETED1,428
UNKNOWN213
TERMINATED99
RECRUITING38
NOT_YET_RECRUITING28
ACTIVE_NOT_RECRUITING26
WITHDRAWN24
SUSPENDED5
ENROLLING_BY_INVITATION3
NO_LONGER_AVAILABLE1

Phase mix

NA502
PHASE3364
PHASE1280
PHASE4277
PHASE2249
EARLY_PHASE115
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.